Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

By D. Planas, T. Bruel, L. Grzelak, F. Guivel-Benhassine, I. Staropoli, F. Porrot, C. Planchais, Julian Buchrieser, M. M. Rajah, Elodie Bishop and 23 more. Nature Medicine, 2021

687 citations recorded by the source corpus.

Subfields: Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/f9d6557760b4fb00a457c94303a0f5db7d60b443

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. N. Peiffer-Smadja
2. C. MacDonald
3. Y. Kherabi
4. Thibault Fiolet
5. J. Ghosn

Citations in the corpus

• Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review (2021, positive): “These variants may cause more severe disease [4] and/or have a potential ability to escape the host or vaccine-induced immune response [7,10].”